经动脉栓塞作为前颅窝硬脑膜动静脉瘘一线治疗:单中心研究
该单中心回顾性研究纳入2010至2023年间接受治疗的14例前颅窝硬脑膜动静脉瘘患者(共15个瘘),以经动脉n-BCA栓塞作为一线方案。仅经动脉栓塞的完全闭塞率为69%(9/13),血管内治疗总体完全闭塞率为79%(11/14),经眼动脉途径13例无手术并发症,所有患者视力保留。作者认为经动脉n-BCA栓塞作为一线治疗安全可行。
要点
- 前颅窝硬脑膜动静脉瘘经动脉n-BCA栓塞作为一线方案,仅经动脉途径完全闭塞率为69%(9/13)。
- 血管内治疗总体完全闭塞率为79%(11/14),经眼动脉途径13例无手术并发症,所有患者视力保留。
- 血管内治疗失败后3例行手术治疗,随访时所有患者前颅窝硬脑膜动静脉瘘均完全闭塞。
核心结论
- 经动脉n-BCA栓塞作为前颅窝硬脑膜动静脉瘘的一线治疗策略安全可行;本研究中经眼动脉栓塞未发生视力并发症。
研究设计与样本
- 单中心回顾性研究,纳入2010至2023年阿姆斯特丹大学医学中心连续治疗的14例前颅窝硬脑膜动静脉瘘患者(共15个瘘);以经动脉栓塞为一线方案,经静脉治疗和手术用于经动脉栓塞失败者;以血管造影治愈率、手术并发症和临床结局评估治疗。
诊断标准与关键数值
- 仅经动脉栓塞的完全闭塞率为69%(9/13);血管内治疗总体完全闭塞率为79%(11/14);经眼动脉途径导航和栓塞13例,无手术并发症;所有患者视力保留;随访时所有患者前颅窝硬脑膜动静脉瘘完全闭塞。
临床应用与阅片要点
- 作者认为经动脉n-BCA栓塞可作为前颅窝硬脑膜动静脉瘘安全可行的一线治疗策略;本研究中经眼动脉栓塞未发生视力并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Endovascular treatment has been increasingly used for anterior cranial fossa dural AVFs. Evidence on the safety and efficacy of different endovascular treatment strategies is limited. We report clinical and angiographic outcomes of patients with anterior cranial fossa dural AVFs who underwent treatment using transarterial embolization with n-BCA as a first-line approach.
MATERIALS AND METHODS: Consecutive patients undergoing treatment for anterior cranial fossa dural AVFs at the Amsterdam University Medical Centers between 2010 and 2023 were retrospectively included. Transarterial embolization was used as a first-line approach, while transvenous treatment and surgery were used in cases of unsuccessful transarterial embolization. Treatment was evaluated on the basis of the angiographic cure rate, procedural complications, and clinical outcome.
RESULTS: Fourteen patients were included with 15 anterior cranial fossa dural AVFs. All patients underwent primary endovascular treatment (12 transarterial, 1 transvenous, and 1 combined). Complete occlusion using only transarterial embolization was reached in 69% of patients (9/13), while the overall complete occlusion by endovascular treatment was reached in 79% of patients (11/14). Navigation and embolization were performed through the ophthalmic artery in 13 patients, with no procedural complications. Visual acuity was preserved in all patients. Three patients underwent an operation after failed endovascular treatment. All patients had complete anterior cranial fossa dural AVF occlusion at follow-up.
CONCLUSIONS: Treatment of anterior cranial fossa dural AVFs using transarterial embolization with n-BCA as a first-line approach is a safe and feasible first-line treatment strategy. No visual complications due to embolization through the ophthalmic artery occurred in this study.
引用
- Puylaert CAJ, van den Berg R, Coert BA, et al. Transarterial Embolization of Anterior Cranial Fossa Dural AVFs as a First-Line Approach: A Single-Center Study. AJNR Am J Neuroradiol. 2024. PMID: 38176732. doi:10.3174/ajnr.A8092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。